TUBG1

TUBG1 encodes γ-tubulin, a GTPase that organizes microtubule architecture and is essential for postmitotic neuronal positioning during cortical development (PMID:23603762). Pathogenic missense variants, including Y92C, reduce microtubule dynamics and impair neuronal locomotion—bipolar neurons position their centrosomes correctly but fail to initiate migration—without producing major structural centrosome defects, and a knock-in mouse recapitulates the neuroanatomical, behavioral, and epileptic phenotypes, establishing TUBG1 as a cause of cortical malformation (PMID:31086189). In mammalian cells TUBG1 assembles into a meshwork that serves as an interacting platform directing centrosome motility (PMID:37685969), and its activity extends beyond microtubules to maintain vimentin and lamin B networks while restraining actin, with N- and C-terminal fragments separably restoring these systems (PMID:40013266). In disease contexts, γ-tubulin loss impairs canonical Wnt/β-catenin signaling during brain development (PMID:39215931) and operates within an E2F1–RB1 axis: pharmacological TUBG1 inhibition elevates RB1, drives E2F1-mediated procaspase-3 upregulation, and selectively kills RB1-deficient tumor cells (PMID:40019206), consistent with TUBG1 silencing triggering G1 arrest and ATR/P53-dependent apoptosis in carcinoma cells (PMID:37806848).

1. 2013 High

   Established that γ-tubulin is required not only for cell division but specifically for postmitotic neuronal migration in the developing cortex, and that disease variants act through microtubule dynamics.

   Evidence In vivo mouse Tubg1 knockdown (shRNA) plus mutant γ-tubulin expression in yeast microtubule assay

   PMID:23603762

   Open questions at the time

   • Did not resolve whether the migration defect reflects loss of nucleation versus altered dynamics
   • No structural mapping of variant effects
2. 2019 High

   Defined the cellular defect underlying TUBG1-linked malformation: reduced microtubule dynamics impair locomotion initiation despite correct centrosome positioning and intact centrosome function.

   Evidence In utero electroporation, Tubg1Y92C/+ knock-in mouse, live microtubule dynamics in patient fibroblasts, EEG/behavioral phenotyping

   PMID:31086189

   Open questions at the time

   • Mechanism linking reduced dynamics to locomotion failure not resolved
   • Centrosome-independent function only inferred, not directly assayed at molecular level
3. 2023 Medium

   Showed TUBG1 forms a cellular meshwork that functions as a positional platform for centrosome movement, extending its role beyond a punctate nucleation site.

   Evidence Live-cell imaging of GFP-TUBG1 and mRFP-centrin 2 with sgRNA knockdown and centrosome tracking

   PMID:37685969

   Open questions at the time

   • Molecular composition of the meshwork not defined
   • Single lab, two approaches
   • How the meshwork mechanically couples to centrosomes unknown
4. 2023 Medium

   Placed TUBG1 upstream of cell-cycle and apoptosis control in carcinoma cells, linking its loss to G1 arrest via cyclin-CDK suppression and ATR/P53-dependent apoptosis.

   Evidence siRNA silencing in HCC cell lines with flow cytometry, colony formation, and Western blot of pathway components

   PMID:37806848

   Open questions at the time

   • Correlative pathway readouts without direct epistasis
   • Single lab
   • Whether effects are direct or secondary to mitotic disruption unclear
5. 2024 Medium

   Connected γ-tubulin to a signaling pathway, showing its deficiency impairs canonical Wnt/β-catenin activity during brain development and microcephaly phenotypes.

   Evidence Zebrafish somatic CRISPR/Cas9 tubg1 mutant with Wnt/β-catenin reporter and neurogenesis analysis

   PMID:39215931

   Open questions at the time

   • Mechanistic link between γ-tubulin and Wnt signaling not defined
   • Whether Wnt effect is cytoskeleton-dependent unknown
6. 2025 Medium

   Demonstrated paralog-selective druggability of TUBG1 within an E2F1-RB1 network, enabling selective killing of RB1-deficient tumors via procaspase-3 upregulation.

   Evidence Small-molecule TUBG1 inhibitor (L12), RB1/E2F1/procaspase-3 Western blot, E2F1 knockdown rescue, SCLC xenograft

   PMID:40019206

   Open questions at the time

   • Direct target engagement of L12 with TUBG1 not structurally confirmed
   • Mechanism by which TUBG1 inhibition elevates RB1 unresolved
7. 2025 Medium

   Broadened TUBG1's structural role beyond microtubules, showing it coordinates vimentin and lamin B networks and that distinct termini carry separable structural functions.

   Evidence sgRNA knockdown with N- and C-terminal fragment rescue and immunofluorescence of cytoskeletal components

   PMID:40013266

   Open questions at the time

   • Direct binding to vimentin/lamin B not demonstrated
   • Single lab
   • Whether intermediate-filament effects are direct or secondary to microtubule loss unclear

• The molecular mechanism by which γ-tubulin coordinates multiple cytoskeletal systems and intersects Wnt and E2F1-RB1 signaling remains undefined.
• No structural model of the TUBG1 meshwork
• Direct partners outside the microtubule system not identified
• Causal link between cytoskeletal and signaling roles unresolved